FFCP PHASE2:Hg19::chr1:9129735..9129762,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p4@SLC2A5 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_4_at_SLC2A5_5end |
Coexpression cluster: | C173_Adipocyte_mature_skin_left_Hepatocyte_Osteoblast_adipose |
Association with transcript: | 12bp_to_ENST00000377424_5end |
EntrezGene: | SLC2A5 |
HGNC: | 11010 |
UniProt: | P22732 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p4@SLC2A5 |
---|
0
10
20
30
40
50
60
70
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 3.51e-26 | 24 |
pro-B cell | 3.51e-26 | 24 |
B cell | 1.83e-16 | 14 |
fat cell | 1.08e-14 | 15 |
hematopoietic oligopotent progenitor cell | 7.91e-13 | 161 |
hematopoietic multipotent progenitor cell | 7.91e-13 | 161 |
hematopoietic stem cell | 9.08e-13 | 168 |
hematopoietic cell | 1.43e-11 | 177 |
lymphocyte | 1.89e-10 | 53 |
common lymphoid progenitor | 1.89e-10 | 53 |
Showing 1 to 10 of 21 entries
Ontology term | p-value | n |
---|---|---|
omentum | 1.10e-13 | 6 |
peritoneum | 1.10e-13 | 6 |
abdominal cavity | 1.10e-13 | 6 |
visceral peritoneum | 1.10e-13 | 6 |
connective tissue | 1.52e-09 | 371 |
cavity lining | 8.58e-09 | 12 |
serous membrane | 8.58e-09 | 12 |
spinal cord | 4.41e-07 | 3 |
dorsal region element | 4.41e-07 | 3 |
dorsum | 4.41e-07 | 3 |
Showing 1 to 10 of 10 entries
Ontology term | p-value | n |
---|---|---|
hematologic cancer | 1.51e-13 | 51 |
immune system cancer | 1.51e-13 | 51 |
myeloid leukemia | 3.30e-12 | 31 |
leukemia | 2.21e-10 | 39 |
Showing 1 to 4 of 4 entries